192 related articles for article (PubMed ID: 34118336)
21. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
Layek B; Singh J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
[TBL] [Abstract][Full Text] [Related]
22. Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview.
Hema S; Thambiraj S; Shankaran DR
J Nanosci Nanotechnol; 2018 Aug; 18(8):5171-5191. PubMed ID: 29458568
[TBL] [Abstract][Full Text] [Related]
23. Dendrimer nanoparticles for colorectal cancer applications.
Carvalho MR; Reis RL; Oliveira JM
J Mater Chem B; 2020 Feb; 8(6):1128-1138. PubMed ID: 31971528
[TBL] [Abstract][Full Text] [Related]
24. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
25. Chitosan nanopolymers: An overview of drug delivery against cancer.
Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
[TBL] [Abstract][Full Text] [Related]
26. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
27. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
[TBL] [Abstract][Full Text] [Related]
28. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
30. Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer.
Shen MY; Liu TI; Yu TW; Kv R; Chiang WH; Tsai YC; Chen HH; Lin SC; Chiu HC
Biomaterials; 2019 Mar; 197():86-100. PubMed ID: 30641267
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
Jiang H; Shi X; Yu X; He X; An Y; Lu H
Pharm Res; 2018 Feb; 35(4):73. PubMed ID: 29476264
[TBL] [Abstract][Full Text] [Related]
32. Understanding Nanotechnology in the Treatment of Oral Cancer: A Comprehensive Review.
Taneja N; Alam A; Patnaik RS; Taneja T; Gupta S; K SM
Crit Rev Ther Drug Carrier Syst; 2021; 38(6):1-48. PubMed ID: 34587428
[TBL] [Abstract][Full Text] [Related]
33. Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine.
Derakhshankhah H; Izadi Z; Alaei L; Lotfabadi A; Saboury AA; Dinarvand R; Divsalar A; Seyedarabi A; Barzegari E; Evini M
Anticancer Agents Med Chem; 2017; 17(10):1317-1327. PubMed ID: 28270073
[TBL] [Abstract][Full Text] [Related]
34. A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil.
Singh S; Kotla NG; Tomar S; Maddiboyina B; Webster TJ; Sharma D; Sunnapu O
Int J Nanomedicine; 2015; 10():7175-82. PubMed ID: 26648721
[TBL] [Abstract][Full Text] [Related]
35. Novel nanoparticulate systems for lung cancer therapy: an updated review.
Madni A; Batool A; Noreen S; Maqbool I; Rehman F; Kashif PM; Tahir N; Raza A
J Drug Target; 2017 Jul; 25(6):499-512. PubMed ID: 28151021
[TBL] [Abstract][Full Text] [Related]
36. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
[TBL] [Abstract][Full Text] [Related]
37. A Comprehensive Review on Liver Targeting: Emphasis on Nanotechnology- based Molecular Targets and Receptors Mediated Approaches.
Mishra AK; Pandey M; Dewangan HK; Sl N; Sahoo PK
Curr Drug Targets; 2022; 23(15):1381-1405. PubMed ID: 36065923
[TBL] [Abstract][Full Text] [Related]
38. Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics.
Liu Y; Ou H; Pei X; Jiang B; Ma Y; Liu N; Wen C; Peng C; Hu X
Curr Med Chem; 2021; 28(31):6307-6322. PubMed ID: 32503398
[TBL] [Abstract][Full Text] [Related]
39. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
[TBL] [Abstract][Full Text] [Related]
40. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.
Abdellatif AAH; Alshubrumi AS; Younis MA
AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
